next generation colorectal cancer screening


CRCbioscreen strengthens leadership team by appointing Henri Theunissen as CEO

November 1, 2021, click here

CRCbioscreen announces publication of clinical validation data of a multitarget faecal immunochemical test for colorectal cancer screening

July 26, 2021, click here

Health˜Holland has awarded a € 1.003.275 TKI-LSH grant to NKI and CRCbioscreen  for the prospective clinical validation of a novel multitarget FIT in 13000 participants of the Dutch CRC screening program (mtFIT study)

July, 2021, click here

CRCbioscreen raises EUR 875K seed funding for developing a multitarget faecal immunochemical test for improved colorectal cancer screening

March 17, 2021, click here